PCN116 COST-EFFECTIVENESS OF PEMBROLIZUMAB (KEYTRUDA®) PLUS PLATINUM-PEMETREXED FOR FIRST-LINE TREATMENT OF METASTATIC NON-SQUAMOUS NON-SMALL CELL LUNG CANCER IN FRANCE

Saved in:
Bibliographic Details
Published in:Value in health 2019-11, Vol.22, p.S458
Main Authors: Chouaid, C., Bensimon, L., Millier, A., Clay, E., Insinga, R., Arunachalam, A., Khandelwal, A., Levy Bachelot, L., Levy, P.
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1098-3015
DOI:10.1016/j.jval.2019.09.313